Keyword: KKR

Lonza

Lonza bulks up with $5.5B deal for Capsugel

Swiss CDMO Lonza has pulled the trigger on a $5.5 billion deal to acquire the U.S.-based contract capsule and drug producer Capsugel to create another sizable force in contract manufacturing.
Agreement

Gland Pharma and KKR Announce Partnership

Gland Pharma and KKR Announce Partnership KKR & Co. L.P. Marks the largest private equity investment in an Indian pharmaceutical company MUMBAI, India-- Gland Pharma Limited ("Company"...